Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Starpharma Holdings Profit Margin 2011-2020 | SPHRY

Current and historical gross margin, operating margin and net profit margin for Starpharma Holdings (SPHRY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Starpharma Holdings net profit margin as of June 30, 2020 is 0%.
  
Starpharma Holdings Annual Profit Margins
Starpharma Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.503B $0.004B
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.867B 10.04
Amgen (AMGN) United States $144.431B 15.59
CSL (CSLLY) Australia $98.706B 0.00
Gilead Sciences (GILD) United States $85.949B 9.15
Moderna (MRNA) United States $64.799B 129.10
Vertex Pharmaceuticals (VRTX) United States $56.197B 23.14
Illumina (ILMN) United States $55.630B 80.22
Regeneron Pharmaceuticals (REGN) United States $55.043B 15.76
BioNTech SE (BNTX) Germany $46.558B 33.76
Biogen (BIIB) United States $42.187B 9.66
Alexion Pharmaceuticals (ALXN) United States $38.345B 14.57
BeiGene (BGNE) Cayman Islands $29.309B 0.00
Seagen (SGEN) United States $26.768B 46.24
Genmab (GMAB) Denmark $24.320B 28.52
Genmab (GNMSF) Denmark $23.086B 5.31
Horizon Therapeutics Public (HZNP) Ireland $20.710B 26.48
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.582B 0.00
CureVac (CVAC) Germany $20.559B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.806B 45.69
Incyte (INCY) United States $18.170B 35.92
Exact Sciences (EXAS) United States $16.596B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.951B 0.00
Bio-Techne Corp (TECH) United States $15.610B 82.08
Zai Lab (ZLAB) China $14.480B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.058B 128.22
ARGENX SE-ADR (ARGX) Netherlands $13.971B 0.00
Guardant Health (GH) United States $11.411B 0.00
QIAGEN (QGEN) Netherlands $10.665B 18.94
Novavax (NVAX) United States $9.758B 0.00
Repligen (RGEN) United States $9.441B 85.13
AbCellera Biologics (ABCL) $8.602B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.080B 0.00
Mirati Therapeutics (MRTX) United States $8.057B 0.00
Exelixis (EXEL) United States $8.010B 127.80
Acceleron Pharma (XLRN) United States $7.654B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.482B 0.00
Fate Therapeutics (FATE) United States $7.213B 0.00
Ascendis Pharma (ASND) Denmark $7.105B 0.00
Denali Therapeutics (DNLI) United States $6.532B 234.35
Halozyme Therapeutics (HALO) United States $6.127B 33.62
Sarepta Therapeutics (SRPT) United States $6.067B 0.00
Blueprint Medicines (BPMC) United States $5.627B 17.13
Vir Biotechnology (VIR) United States $5.489B 0.00
Galapagos (GLPG) Belgium $4.991B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.950B 17.93
Adaptive Biotechnologies (ADPT) United States $4.846B 0.00
I-Mab (IMAB) China $4.698B 0.00
Intellia Therapeutics (NTLA) United States $4.569B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.545B 0.00
Twist Bioscience (TWST) United States $4.532B 0.00
Beam Therapeutics (BEAM) United States $4.501B 0.00
NeoGenomics (NEO) United States $4.494B 762.20
Certara (CERT) United States $3.941B 0.00
Legend Biotech (LEGN) United States $3.937B 0.00
Arena Pharmaceuticals (ARNA) United States $3.730B 0.00
SpringWorks Therapeutics (SWTX) United States $3.586B 0.00
Alkermes (ALKS) Ireland $3.572B 0.00
Apellis Pharmaceuticals (APLS) United States $3.563B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.487B 0.00
Emergent Biosolutions (EBS) United States $3.322B 6.62
Arvinas (ARVN) United States $3.278B 0.00
Intra-Cellular Therapies (ITCI) United States $3.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.883B 40.74
Reata Pharmaceuticals (RETA) United States $2.842B 0.00
MorphoSys AG (MOR) Germany $2.751B 0.00
Insmed (INSM) United States $2.715B 0.00
Amicus Therapeutics (FOLD) United States $2.525B 0.00
Berkeley Lights (BLI) United States $2.477B 0.00
Vericel (VCEL) United States $2.353B 634.63
Instil Bio (TIL) United States $2.265B 0.00
Editas Medicine (EDIT) United States $2.253B 0.00
Global Blood Therapeutics (GBT) United States $2.253B 0.00
ALX Oncology Holdings (ALXO) United States $2.229B 0.00
NGM Biopharmaceuticals (NGM) United States $2.201B 0.00
Ligand Pharmaceuticals (LGND) United States $2.157B 36.08
Myriad Genetics (MYGN) United States $2.110B 0.00
Revance Therapeutics (RVNC) United States $2.079B 0.00
Seres Therapeutics (MCRB) United States $2.065B 0.00
Kymera Therapeutics (KYMR) United States $2.050B 0.00
Bluebird Bio (BLUE) United States $2.045B 0.00
Arcus Biosciences (RCUS) United States $2.025B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.016B 0.00
Heska (HSKA) United States $2.006B 874.54
Deciphera Pharmaceuticals (DCPH) United States $2.005B 0.00
Myovant Sciences (MYOV) United Kingdom $1.945B 0.00
Sorrento Therapeutics (SRNE) United States $1.898B 0.00
Atea Pharmaceuticals (AVIR) United States $1.896B 0.00
Cytokinetics (CYTK) United States $1.860B 0.00
PHARMA MAR SA (PHMMF) Spain $1.843B 0.00
Seer (SEER) $1.804B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.738B 0.00
Ocugen (OCGN) United States $1.735B 0.00
Amarin (AMRN) Ireland $1.729B 0.00
Morphic Holding (MORF) United States $1.696B 0.00
Genetron Holdings (GTH) China $1.681B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.586B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
REGENXBIO (RGNX) United States $1.536B 0.00
BioAtla (BCAB) United States $1.526B 0.00
Bionano Genomics (BNGO) United States $1.506B 0.00
C4 Therapeutics (CCCC) United States $1.505B 0.00
UniQure (QURE) Netherlands $1.493B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.490B 0.00
PureTech Health (PRTC) United States $1.488B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.463B 0.00
Northwest Biotherapeutics (NWBO) United States $1.456B 0.00
Precigen (PGEN) United States $1.428B 0.00
Castle Biosciences (CSTL) United States $1.382B 0.00
Inovio Pharmaceuticals (INO) United States $1.372B 0.00
Alector (ALEC) United States $1.356B 0.00
Protagonist Therapeutics (PTGX) United States $1.339B 0.00
Zymeworks (ZYME) Canada $1.320B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.267B 0.00
Zealand Pharma (ZEAL) Denmark $1.260B 0.00
Curis (CRIS) United States $1.242B 0.00
Avid Bioservices (CDMO) United States $1.222B 0.00
Repare Therapeutics (RPTX) Canada $1.198B 0.00
Codexis (CDXS) United States $1.180B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Nurix Therapeutics (NRIX) United States $1.151B 0.00
Coherus BioSciences (CHRS) United States $1.146B 0.00
Keros Therapeutics (KROS) United States $1.139B 0.00
Shattuck Labs (STTK) United States $1.123B 0.00
Travere Therapeutics (TVTX) United States $1.105B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.095B 0.00
MannKind (MNKD) United States $1.074B 0.00
Celldex Therapeutics (CLDX) United States $1.073B 0.00
MiMedx (MDXG) United States $1.058B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.041B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.036B 32.72
Mersana Therapeutics (MRSN) United States $1.017B 0.00
Prothena (PRTA) Ireland $1.015B 0.00
Pliant Therapeutics (PLRX) United States $1.007B 0.00
Scholar Rock Holding (SRRK) United States $0.961B 0.00
Epizyme (EPZM) United States $0.931B 0.00
G1 THERAPEUTICS (GTHX) United States $0.922B 0.00
Nkarta (NKTX) United States $0.918B 0.00
Sutro Biopharma (STRO) United States $0.908B 0.00
Mesoblast (MESO) Australia $0.907B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.894B 0.00
Dynavax Technologies (DVAX) United States $0.894B 0.00
Affimed (AFMD) Germany $0.865B 0.00
Merus (MRUS) Netherlands $0.849B 0.00
Pharming Group (PHAR) Netherlands $0.777B 0.00
Avidity Biosciences (RNA) United States $0.768B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.760B 0.00
Pharming Group (PHGUF) Netherlands $0.754B 20.08
Adaptimmune Therapeutics (ADAP) United Kingdom $0.749B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.749B 0.00
VBI Vaccines (VBIV) United States $0.742B 0.00
Agenus (AGEN) United States $0.718B 0.00
AnaptysBio (ANAB) United States $0.714B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.710B 0.00
Cellectis S.A (CLLS) France $0.704B 0.00
DBV Technologies S.A (DBVT) France $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.683B 0.00
Bolt Biotherapeutics (BOLT) United States $0.683B 0.00
Cara Therapeutics (CARA) United States $0.661B 57.39
Orchard Therapeutics (ORTX) United Kingdom $0.657B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
IDEAYA Biosciences (IDYA) United States $0.642B 0.00
Kadmon Holdings (KDMN) United States $0.641B 0.00
Inhibrx (INBX) United States $0.632B 0.00
Anika Therapeutics (ANIK) United States $0.629B 0.00
Prometheus Biosciences (RXDX) United States $0.627B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.625B 0.00
Clovis Oncology (CLVS) United States $0.614B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.602B 0.00
MeiraGTx Holdings (MGTX) United States $0.576B 0.00
ALBIREO PHARMA (ALBO) United States $0.574B 0.00
Adagene (ADAG) China $0.553B 0.00
Inventiva S.A (IVA) France $0.549B 0.00
Compugen (CGEN) Israel $0.547B 0.00
Precision BioSciences (DTIL) United States $0.546B 0.00
CytomX Therapeutics (CTMX) United States $0.530B 0.00
RAPT THERAPTICS (RAPT) United States $0.515B 0.00
XBiotech (XBIT) United States $0.513B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.507B 0.00
Verastem (VSTM) United States $0.505B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Athenex (ATNX) United States $0.475B 0.00
Neoleukin Therapeutics (NLTX) United States $0.475B 0.00
ChromaDex (CDXC) United States $0.469B 0.00
HOOKIPA Pharma (HOOK) United States $0.456B 0.00
Geron (GERN) United States $0.456B 0.00
AC Immune SA (ACIU) Switzerland $0.451B 0.00
Clene (CLNN) United States $0.435B 0.00
ANI Pharmaceuticals (ANIP) United States $0.434B 11.97
Cue Biopharma (CUE) United States $0.429B 0.00
Forte Biosciences (FBRX) United States $0.427B 0.00
Adicet Bio (ACET) United States $0.427B 0.00
Gritstone Bio (GRTS) United States $0.425B 0.00
Angion Biomedica (ANGN) United States $0.415B 0.00
Puma Biotechnology (PBYI) United States $0.414B 0.00
Spero Therapeutics (SPRO) United States $0.413B 0.00
Seelos Therapeutics (SEEL) United States $0.408B 0.00
SESEN BIO, INC (SESN) United States $0.405B 0.00
Codiak BioSciences (CDAK) United States $0.401B 0.00
Amryt Pharma (AMYT) United Kingdom $0.397B 0.00
BeyondSpring (BYSI) United States $0.382B 0.00
Athersys (ATHX) United States $0.375B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.371B 0.00
Oncobiologics (OTLK) United States $0.363B 0.00
Fortress Biotech (FBIO) United States $0.358B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.357B 0.00
Opthea (OPT) Australia $0.353B 0.00
Adverum Biotechnologies (ADVM) United States $0.353B 0.00
BioDelivery Sciences (BDSI) United States $0.351B 14.24
AquaBounty Technologies (AQB) United States $0.347B 0.00
Selecta Biosciences (SELB) United States $0.337B 0.00
XOMA (XOMA) United States $0.337B 157.47
SQZ Biotechnologies (SQZ) United States $0.331B 0.00
Theratechnologies (THTX) Canada $0.329B 0.00
Kala Pharmaceuticals (KALA) United States $0.327B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.323B 0.00
Syros Pharmaceuticals (SYRS) United States $0.323B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.322B 0.00
Fulcrum Therapeutics (FULC) United States $0.322B 0.00
Cardiff Oncology (CRDF) United States $0.321B 0.00
UROGEN PHARMA (URGN) United States $0.318B 0.00
Innate Pharma S.A (IPHA) France $0.317B 0.00
WAVE Life Sciences (WVE) Singapore $0.310B 0.00
Cogent Biosciences (COGT) United States $0.308B 0.00
Frequency Therapeutics (FREQ) United States $0.296B 0.00
Bellus Health (BLU) Canada $0.285B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kaleido Biosciences (KLDO) $0.269B 0.00
Talis Biomedical (TLIS) United States $0.258B 0.00
Kamada (KMDA) Israel $0.255B 17.36
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.255B 0.00
Arbutus Biopharma (ABUS) United States $0.253B 0.00
Trevena (TRVN) United States $0.249B 0.00
OVID THERAPEUTC (OVID) United States $0.243B 2.39
Chiasma (CHMA) United States $0.232B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.232B 0.00
CorMedix Inc (CRMD) United States $0.230B 0.00
Prima BioMed (IMMP) Australia $0.230B 0.00
NextCure (NXTC) United States $0.225B 0.00
Cerecor (CERC) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.209B 0.00
Eton Pharmaceuticals (ETON) United States $0.202B 0.00
Kindred Biosciences (KIN) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.192B 0.00
VTv Therapeutics (VTVT) United States $0.190B 0.00
Checkpoint Therapeutics (CKPT) United States $0.188B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
X4 Pharmaceuticals (XFOR) United States $0.180B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Erytech Pharma SA (ERYP) France $0.177B 0.00
Aptinyx (APTX) United States $0.172B 0.00
Voyager Therapeutics (VYGR) United States $0.172B 4.43
Nicox SA (NICXF) France $0.170B 0.00
Applied Genetic Technologies (AGTC) United States $0.166B 0.00
Strongbridge Biopharma (SBBP) United States $0.159B 0.00
ObsEva SA (OBSV) Switzerland $0.157B 0.00
Antibe Therapeutics (ATBPF) Canada $0.154B 0.00
Biofrontera AG (BFRA) Germany $0.154B 0.00
LogicBio Therapeutics (LOGC) United States $0.152B 0.00
INmune Bio (INMB) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
Synlogic (SYBX) United States $0.141B 0.00
Clearside Biomedical (CLSD) United States $0.137B 0.00
Abeona Therapeutics (ABEO) United States $0.137B 0.00
ABVC BioPharma (ABVC) United States $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
Exicure (XCUR) United States $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.129B 0.00
Liminal BioSciences (LMNL) Canada $0.128B 0.00
Novogen (KZIA) Australia $0.125B 0.00
Orgenesis (ORGS) United States $0.124B 0.00
Galena Biopharma (SLS) United States $0.123B 0.00
DiaMedica Therapeutics (DMAC) United States $0.122B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.119B 0.00
Eyenovia (EYEN) United States $0.118B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.117B 0.00
Pluristem Therapeutics (PSTI) Israel $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.110B 0.00
Beyond Air (XAIR) United States $0.103B 0.00
Dyadic (DYAI) United States $0.103B 0.00
Aptevo Therapeutics (APVO) United States $0.102B 0.00
Longeveron (LGVN) United States $0.100B 0.00
Cyclerion Therapeutics (CYCN) United States $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.098B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
Aytu BioPharma (AYTU) United States $0.096B 0.00
TRACON Pharmaceuticals (TCON) United States $0.095B 0.00
Vascular Biogenics (VBLT) Israel $0.095B 0.00
Leap Therapeutics (LPTX) United States $0.094B 0.00
Celsion (CLSN) United States $0.090B 0.00
Evogene (EVGN) Israel $0.090B 0.00
Lumos Pharma (LUMO) United States $0.083B 0.00
AIkido Pharma (AIKI) United States $0.081B 0.00
Celyad SA (CYAD) Belgium $0.081B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.079B 0.00
Edesa Biotech (EDSA) Canada $0.079B 0.00
Zosano Pharma (ZSAN) United States $0.079B 0.00
Adocia (ADOCY) France $0.077B 0.00
Cleveland BioLabs (CBLI) United States $0.072B 0.00
ARIDIS PHARMACT (ARDS) United States $0.072B 0.00
Purple Biotech (PPBT) Israel $0.070B 0.00
Entera Bio (ENTX) Israel $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.066B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.066B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.060B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
ATyr Pharma (LIFE) United States $0.059B 0.00
BioCardia (BCDA) United States $0.058B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Advaxis (ADXS) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.055B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
AnPac Bio-Medical Science (ANPC) China $0.050B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Organovo Holdings (ONVO) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.046B 0.00
Cyclo Therapeutics (CYTH) United States $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.043B 1.03
Enveric Biosciences (ENVB) United States $0.042B 0.00
Invo BioScience (INVO) United States $0.041B 0.00
Yumanity Therapeutics (YMTX) United States $0.037B 0.00
Vyant Bio (VYNT) United States $0.037B 0.00
Soligenix (SNGX) United States $0.036B 0.00
GeoVax Labs (GOVX) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.026B 0.00
Vallon Pharmaceuticals (VLON) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.022B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00